Final!!

MF-10 Tenth Microfluidics Consortium

MF-10.3

(Open Meeting – Day Delegates + Members),

May 16th Cambridge UK

Agenda

Delegate List

Speaker Profiles

Table-top Demonstrations

Hotel and Travel Recommendations

2

The Tenth Microfluidics Consortium brings together current and future stakeholders from across a wide range of backgrounds with a shared interest in facilitating the growth of the industry through better understanding of the challenges, opportunities and choices which it faces.

Our current membership includes: Alveole (FR); BD Biosciences (USA) ;EV Group (A); Micronit (NL); Danaher (USA); Dolomite (UK) ; Fluigent (F); HP (USA); Dublin City University / Fraunhofer (EI) ; IDEX Health and Science (D/US); IPGG (FR); Philips (NL); Cryopak (USA); IMT (CH), Labcyte (US), National Research Council of Canada (Can) ; Susos (CH); z-microsystems (A); University of Calfornia Riverside (USA) and University of Cambridge (UK).

We organize closed meetings for our members on both sides of the Atlantic where we seek to promote our mission “to grow the market for microfluidics enabled products and services” by

- Finding shared interest across the landscape of applications - Championing modularity and standards where appropriate - Engaging with key industry influencers

While helping our members to do deals along the way.

With the support of the Knowles Laboratory at the University of Cambridge on this occasion we are also reaching out to selected guests in Europe and beyond our membership in an Open Meeting on May 16 seeking to engage them in our vision, projects and thinking. On this occasion our overarching theme will be Microfluidics meets Electronics.

On May 17 there is an opportunity for 1-2-1 meetings as well as the (option for members only) meeting of the ParticleGEN co-development-consortium which has spun out of MF10.

May 16th (Open day)

Location: Trinity Centre, Cambridge Science Park

The Trinity Centre is the events location at the heart of the Cambridge Science Park which is the

largest of Cambridge’s nine science parks. It is where several of Cambridge’s Unicorns started life

and also home to the R&D labs of global players such as Astra Zeneca, Cambridge Consultants

and Abbvie.

3

Table-top demos will be on show in the networking area from the following MF10 member organisations:

09:00 Registration / Table Top Demos

09:30 Welcome / Scene Setting / Introductions

Peter Hewkin is CEO of the Centre for Business Innovation, he has facilitated

the MF10 consortium for 10 years and is responsible for the delivery of its mission

to grow the market for Microfluidics enabled products and services. He will

describe the processes which the consortium uses, the successes which it has

achieved and the ideas it has for the future.

4

09:45 Session 1: Research

“Microfluidic ion pumps for drug delivery in the brain”

George Malliaras Prince Philip Professor of Technology, University of Cambridge.

George Malliaras received a BS in Physics from the Aristotle University (Greece) in 1991, and a PhD in Mathematics and Physical Sciences, cum laude, from the University of Groningen (the Netherlands) in 1995. After postdocs at the University of Groningen and at the IBM Almaden Research Center (California), he joined the faculty in the Department of Materials Science and Engineering at Cornell University (New York) in 1999. From 2006 to 2009 he served as the Lester B. Knight Director of the Cornell NanoScale Science & Technology Facility. He moved to the Ecole des Mines de St. Etienne (France) in 2009, where he started the Department of Bioelectronics and served as Department Head. He joined the University of Cambridge in 2017.

Prof. Malliaras' research on organic electronics and bioelectronics has been recognized with awards from the New York Academy of Sciences (Blavatnik Award), the US National Science Foundation, and DuPont. He is a Fellow of the Materials Research Society and of the Royal Society of Chemistry, and serves as an Associate Editor of Science Advances. He is the Director of the EPSRC IRC in Targeted Delivery for Hard-to-Treat Cancers. Prof. Malliaras is a co-author of 250+ publications in peer-reviewed journals that have received over 23,000 citations. His h-index is 85 (google scholar, 3/19).

“Atomically-thin microwave biosensors with microfluidic channels”

Antonio Lombardo University Lecturer and Director of MRes in Graphene Technology

Antonio Lombardo is a University Lecturer in Integrated Electronics of Graphene and

Related Materials in the Electrical Engineering Division at the Engineering

Department. He is one of academic members of the Cambridge Graphene Centre

and the Director of the Master of Research (MRes) programme in the EPSRC Centre

for Doctoral Training in Graphene Technology. He is also Fellow and Director of

Studies in Engineering at Wolfson College. His research is focussed on design,

fabrication and testing of novel electronic devices based on graphene, other 2D

materials and 2D materials heterostructures for applications in high frequency electronics and biosensing.

Abstract: The interaction between micro and mm-wave with biological materials is a powerful tool for label-

free characterization. Broadband dielectric spectroscopy is the method of choice for such investigations,

where wave propagation in waveguides is modified by the interaction with the biological materials. However,

such interaction is typically studied only on large scales (organs and tissue level), where large quantities of

biological materials are involved. Microfluidics and micro/nano fabrication, together with nanomaterials, allow

miniaturization of devices and therefore enable investigation of the nanoscale interaction between micro/mm-

waves and biological materials, not possible in conventional approaches. In this talk I will present recent

results on atomically-thin DNA sensors, where graphene coplanar waveguides are integrated in a microfluidic

channel.

5

“3D Bioelectronic Devices for the Development of Next Generation Organs-on-Chips”

Charalampos Pitsalidis (PhD), Research Associate, Department of Chemical

Engineering and Biotechnology, University of Cambridge

Organ-on-a-chip technology offers new possibilities to investigate how human organs

respond to different drugs at the preclinical stage. This technology can be thus used in

basic research, as well as in pharma industry for drug development studies. With such

predictive high content assays, failures in drug development can be minimized and the

drug discovery can be substantially accelerated. We have developed a bioelectronic

organ/tissue-on-a-chip platform that supports 3D cell cultures and integrates electronic

components (i.e., electrodes, transistors) to allow non-invasive electronic readouts during tissue formation.

The proposed technology adopts a tubular geometry which allows the facile design of organ-like structures,

while facilitates free flow of nutrients, given its relevance in a variety of biological tissues (e.g., vascular,

gastrointestinal, kidney etc.) and processes (e.g., blood flow). Additionally, it does not require expensive and

time-consuming fabrication techniques, allowing for facile adaptation to commercial settings. This concept

device has recently found application in a highly challenging project which studies the effects of the

microbiome on intestine and brain pathophysiology. I truly believe that in the future such technology will spark

interest in diverse fields and research areas spanning from (bio-)electronics/sensing to tissue engineering.

11:15 Break – Coffee / Networking / Table Top Demos

11:45 Session 2 (Applications Enabled by Microfluidics)

Sean Devenish - Fluidic Analytics

Proteins are the building blocks of life. They form the key components of cells, co-ordinate crucial biochemical processes and carry out the chemical reactions that allow the biological world to function.

By developing products that make protein characterisation faster, more precise, more convenient, more cost-effective and more accurate, Fluidic Analytics is striving to help scientists, healthcare providers and people everywhere to understand the world around them better.

Before starting at Fluidic Analytics Sean had been a postdoctoral fellow in the Department of

Biochemistry at the University of Cambridge, where he researched microfluidic droplets and

protein engineering/evolution, and worked as a postdoc in protein biochemistry at the University of

Canterbury, New Zealand, from where he had obtained a PhD in Chemistry.

Nour Yakdi - Fluigent

Nour is a technical sales manager at Fluigent.

Since 2006, Fluigent develops, manufactures and commercializes innovative microfluidic flow control and fluid handling solutions for laboratories, research units and industrials around the world Enabling full control of your microfluidic systems through pressure, flow and electrical monitoring, Fluigent technologies provide innovating solutions for all your microfluidic and lab-on-a-chip applications (droplet-based drug testing, chromatography, cell perfusion,

6

flow chemistry, cells and parasites separation, dielectophoresis, highly viscous fluids and liquid air manipulations, gene expression analysis in microdroplet, etc).

“Leading Edge Semi-Conductor Process solutions for Microfluidics” Raghu Mokkapati EV

Group

EV Group is a recognized technology and market leader for wafer processing

equipment. The company offers system configurations for R&D and volume

production as well as implementation, process and materials know-how

according to the customer’s needs. Key products include wafer bonding,

lithography and metrology equipment in addition to photoresist coaters,

cleaners and inspection systems. Furthermore, EVG is among the leading

companies in the world providing micro- and nanoimprint equipment capable of

hot embossing, UV-NIL and micro-contact printing. EVG’s technology can thus

provide customers with a total solution for microfluidic device fabrication.

Samuele Tosatti Susos

At SuSoS we offer various solutions for surface technology, such as coating products—coated devices or coating chemicals—and services such as coating, surface analysis and contract research.

Since 2004, we have focused on researching the chemical interactions between substrates and coatings, in order to broaden our understanding and optimize and fine-tune these interactions for many different applications.

Our knowledge can be divided into four different areas:

Polymer-based, thin-film coatings: Using thin films that are only a few nm thick, you can completely change the surface properties of your product. Various functionalities, such as high lubricity under dry and wet conditions, non-fouling properties, or the selective binding of proteins or antibodies on sensor surfaces, can be seamlessly achieved. We also specialize in adhesion promoters and primers.

Coating service: We can coat small series (up to 100 000 parts per annum) right in our own facilities in Dübendorf. With our automated robotic coating system, we are developing industrial coating processes, and supporting our partners with on-site industrial implementation.

Surface-analysis service: With our state-of-the-art analytical technologies, we are able to support you with the characterization of your product and also with product troubleshooting. Chemical and elemental composition, surface topography, coefficient of friction, film thickness or wetting behavior are just some of the many properties we can analyze for you.

Contract Research: We research and implement new technologies; our work is fast, flexible and transparent. Novel applications can be transferred swiftly and easily for your benefit.

What makes us different from our competitors? From our initial contact through to the final implementation, we accompany our clients every step of the way. We attach enormous importance to the all-round service we offer to our customers, from our evaluation of the problem, through advice that is precisely tailor-made to the needs of each customer, to joint project implementation.

7

Sebastain Soeckeler z-microsystems

z-microsystems is specialist for microfluidic consumables and Lab-on-a-chip

applications, from development to high volume production of micro-structured plastic

parts. Micro-tooling and micro injection moulding is our passion. 60 years of

experience and a fresh and dynamic team is awaiting you. We would like to be your

inspiring partner from the idea to highvolume production.

13:15 Lunch / Networking / Tabletop Demos

14:15 Standards for Microfluidics

Henne van Heeren is an acknowledge expert in Microfluidics, for the last

two years he has guided a series of workshops on Microfluidics Standards

and will update the MF10 consortium on his work and latest progress /

outcomes

8

15:00 Microfluidics Hotseat Pitches from microfluidics start ups seeking to engage

with the MF10 Consortium

- Cellesce

Cellesce was founded in 2013 and is built on biochemical and bioprocess engineering expertise from the University of Bath and cell and organoid biology expertise from Cardiff University. In December 2017 Cellesce moved into the Medicentre in Cardiff, Wales.

Cellesce is a Biotech company that has developed a new patented bioprocessing technology for the growing and expansion of organoids. Organoids are a 3D cell structures with organ-like characteristics grown from stem cells. The Company is currently commercialising organoid models that are a powerful new enabling technology in drug discovery and genetics research

- Semarion

Semarion is developing protein fingerprint analysis solutions to enable paradigm shifts in the drug

development process, specifically, patient stratification during clinical trials.

There is a wealth of complex data within biological tissue. Every cell, organ, and body, contain molecular

fingerprints full of hidden information.

Semarion is tapping into that potential. Our technology platform has the potential to quantify 1,000s of

biomarkers simultaneously, in an accurate, affordable, and automated way.

- Acxel

Large area electronics have given us flat panel displays and flexible, wearable devices. ACXEL takes these ‘active’ pixels and puts them to work transporting liquid droplets – precisely and at amazing speed.

Millions of pixels are transformed into tiny engines moving samples around via a high throughput, low cost

and programmable platform, offering a wide range of possibilities in chemistry, biology and medtech.

Each Pitch to be followed by Q & A + feedback Chatham House Rule Applies!

9

15:40 Session 4: Microfluidics meets Electronics

Matthew Hayes

Evonetix is set to revolutionise de novo gene synthesis to facilitate the

fast-growing and exciting field of synthetic biology. Our unique selling

point is driven by high fidelity and parallelisation of gene synthesis.

With the huge increase in DNA sequence information available to mankind over the past ten years, there now exists an unprecedented opportunity to engineer metabolic pathways and organisms, improve industrial processes, create new processes, engineer genomes with new and improved traits and use DNA as a medium for digital data storage.

Only a highly disruptive technology such as ours is likely to achieve the significant improvements in DNA synthesis required to enable and facilitate these opportunities. We therefore believe that we will be well placed to capture part of the growing multi-billion dollar synthetic biology opportunity.

Our technology is based upon a novel silicon array, manufactured with semiconductor microfabrication

techniques and capable of independent control of 10,000 miniaturised reaction sites, allowing massive

parallelism in the DNA synthesis process and therefore very high throughput.

Dr. Pantelis Georgiou

- Microchip Technology enabling rapid diagnostics for infectious diseases

pantelis Georgiou currently holds the position of Reader at Imperial

College London within the Department of Electrical and Electronic Engineering. He is the head of the Bio-inspired Metabolic Technology Laboratory in the Centre for Bio-Inspired Technology; a multi-disciplinary group that invents, develops and demonstrates advanced micro-devices to meet global challenges in biomedical science and healthcare.

His research includes ultra-low power micro-electronics, bio-inspired circuits and systems, lab-on-chip technology and application of micro-electronic technology to create novel medical devices. One of his key research focuses is on new technologies for treatment of diabetes such as the artificial pancreas but also develops novel lab-on-chip technology using CMOS with application in diagnostics for infection and control of antimicrobial resistance (AMR), in addition to wearable technologies for rehabilitation of chronic conditions such as osteoarthritis.

Dr. Georgiou graduated with a 1st Class Honours MEng Degree in Electrical and Electronic Engineering in 2004 and Ph.D. degree in 2008 both from Imperial College London. He has conducted pioneering work in diabetes technology and is now leading the project forward for the development of the first bio-inspired artificial pancreas for treatment of Type I diabetes. In addition to this, he made significant contributions to the development of integrated chemical-sensing systems in CMOS. He has pioneered the development of the Ion-sensitive Field effect Transistor (ISFET), an integrated pH sensor which is currently being used in next generation DNA sequencing machines. In 2013 he was awarded the IET Mike Sergeant Achievement

Medal for his outstanding contributions to engineering and development of the artificial pancreas.

10

Dr Bojan Boskovic. CfBI Consortium Leader for Nano-Carbon Enhanced Materials and Advanced Materials for Additive Manufacturing will describe M3DLoC = Additive Manufacturing of 3D Microfluidic MEMS for Lab-on-a-Chip applications

MEDLOC aims at the employment of multi-material 3D printing technologies for the large-scale fabrication of microfluidic MEMS for lab-on-a-chip and sensing applications. The concept is based on the combination of multimaterial direct-ink-writing method and an extrusion-based 3D printing pilot line, in order to fabricate microstructured detection devices with the ability to perform all steps of chemical analysis in an automated fashion. ThisH2020 project has been funded with Euro7m.

16:45 Wrap-up/ Next meetings (Boston, June; Basel October; Berkeley February)

17:00 Close / Transfer to Christ’s College MF10 Members Dinner .. CfBI Team can

help with car-share/taxi/ transport options.

11

MF10 Members Dinner

Location: The Old Combination Room Christ’ College Cambridge

18:00 Drinks (if the weather is good we will do these out of doors (by

the Mulberry Tree) – and Opportunity to visit chapel, gardens and

other notable features of Christ’s College whose alumni include:

Charles Darwin, John Milton and CP Snow.

18:30 Dinner

This is an opportunity for Members to dine and network in private in exclusive surroundings. Over

dinner we will be addressed by Mark Treherne to stimulate round table discussion about new

opportunities for microfluidics and how the MF10 consortium might facilitate their realisation.

Cellesce has appointed Dr. Mark Treherne as its CEO. Mark, a veteran of the biotech industry, will lead the Company through the next phase of its development programme and commercialisation phase. Cellesce’s pioneering organoid expansion technology is focused on cancer research and compound library screening at scale for drug discovery.

Mark obtained his PhD in pharmacology from Cambridge University and then developed novel 3D tissue culture models, as an academic at the University of Basel until 1992. He has over 25 years’ experience in the discovery of novel treatments for diseases with unmet medical

need. Mark formerly worked at Pfizer where he was responsible for research into neurodegenerative diseases, including using stem-cell derived lines for screening compounds. In 1997, Mark set up Cambridge Drug Discovery as Chief Executive, which was then sold to BioFocus (now part of Charles River) in 2001. Since then, Mark has worked with many early-stage biotechnology companies from foundation through to trade sale. More recently, he was Chief Executive of the Life Sciences Organisation of UK Trade & Investment, which helped UK-based Life Sciences companies raise investment and export overseas.

“We are delighted to have Mark on board,” said John Allbrook, Non-Executive Chairman of Cellesce. “His background and experience in the industry, particularly with early-stage biotech companies, is particularly welcome as we begin to commercialise our organoid technology. Mark’s appointment adds credibility to the fast-developing realisation that organoids have an important role to play in the drug discovery arena.” Close circa 21:00 The CfBI team will be on hand to help with introductions

12

Table-Top Exhibits (in the Networking Area)

Microfluidics-based lab-on-a-chip (LOC) systems have the potential to miniaturise

complex laboratory procedures, integrating them on to a single microchip. These

systems can be used to manipulate small volumes of fluid, but high throughput and

large scale parallel operations are hindered by poor scalability. By combining large-

area-electronics and electro-wetting-on-dielectric (EWOD) technologies, high speed

liquid handling becomes possible.

ACXEL’s active pixel platform uses large-area electronics – thin-film transistors or ‘TFTs’ originally

developed for flat-panel displays – to enable high-throughput liquid transportation.

Programmable logic can coordinate millions of these pixels (active elements) to perform complex tasks

(e.g. droplet dispensing, transportation, reagent mixing, droplet splitting) over a large-scale.

Established in 2005 as the world’s first microfluidic application centre, Dolomite focused on

working with customers to turn their concepts for microfluidic applications into reality.

Today, Dolomite is the world leader in solving microfluidic problems. With offices in the UK,

US and Japan, and distributors throughout the rest of the world, our clients range from

universities developing leading-edge analytical equipment, to manufacturers of chemical,

life sciences and clinical diagnostics systems.

We will be demonstrating Nadia which takes scRNA-Seq to the next level by using automation and flexibility to generate high quality reproducible single cell data.

Nadia is an automated, microfluidic droplet-based platform for single cell research that encapsulates up to 8 samples, in parallel, in under 20 mins. Over 50,000 single cells can be captured per cartridge in a run. The fully automated Nadia Instrument guides users through all relevant steps of the experiment via an easy-to-use touchscreen interface.

For more information please contact us on +44 (0)1763 242491, info@dolomite-microfluidics.com or visit our website www.dolomite-microfluidics.com.

FPC@DCU - the Fraunhofer Project Centre for Embedded Bioanalytical Systems at

Dublin City University - develops microfluidics-enabled “fit-for-industry” (f4i) solutions for

decentralised testing of biosamples at high-technology readiness levels (TRLs). Amongst

the main fields of application of FPC@DCU’s translational research and technology

development (RTD) activities are point-of-use systems supporting decentralised

bioanalytical testing in the context of healthcare, pharma, veterinary medicine, agrifood

and life-science research as well as monitoring of the environment, infrastructures and

industrial processes. Perspective applications are expected in big data / internet of things / artificial

intelligence.

13

EV Group is a recognized technology and market leader for wafer processing

equipment. The company offers system configurations for R&D and volume

production as well as implementation, process and materials know-how

according to the customer’s needs. Key products include wafer bonding,

lithography and metrology equipment in addition to photoresist coaters,

cleaners and inspection systems. Furthermore, EVG is among the leading

companies in the world providing micro- and nanoimprint equipment capable of hot embossing, UV-NIL and

micro-contact printing. EVG’s technology can thus provide customers with a total solution for microfluidic

device fabrication.

Since 2006, Fluigent develops, manufactures and commercializes innovative

microfluidic flow control and fluid handling solutions for laboratories, research

units and industrials around the worldEnabling full control of your microfluidic

systems through pressure, flow and electrical monitoring, Fluigent technologies provide innovating solutions

for all your microfluidic and lab-on-a-chip applications (droplet-based drug testing, chromatography, cell

perfusion, flow chemistry, cells and parasites separation, dielectophoresis, highly viscous fluids and liquid air

manipulations, gene expression analysis in microdroplet, etc).

Indeed, Fluigent has created the market of pressure-driven flow controllers for microfluidic applications and

low volume fluid handling. The products are based on the patented FASTAB technology optimizing stability

and responsiveness of the flow inside your microfluidic systems (chip, microarray, etc).

In addition to the FASTAB technology, Fluigent owns or licences a portfolio of patents worldwide covering its

core technologies in microfluidic flow control, Lab-on-a-chip devices, diagnosis and life science analysis (cell

capture, etc).

Fluidic Analytics develops next generation tools for protein science. Our fundamentally new steady-state laminar flow platform allows proteins to be characterised in solution, under native conditions, quickly, cost-effectively and accurately. This platform brings together–on a single disposable chip–all of the fundamental steps of protein analysis, delivering a “sample in – data out” workflow that is rapid, simple and involves minimal sample preparation. Our technology looks to facilitate studies that distinguish proteins in simple solutions, cell lysates, or even complex mixtures, like blood plasma, by

simultaneously and sensitively measuring their key properties such as concentration, size, molecular weight and charge. And because our technology works best in extremely small volumes under physiological conditions, even highly complex protein solutions will be characterised rapidly, in small sample volumes and without extensive sample preparation.

The Fluidic Analytics platform characterises the properties of biomolecules and their interactions using novel approaches enabled by microfluidics. Our platform analyses proteins in solution under native conditions, obviating the need for tagging or labelling proteins before analysis. Measurements are conducted in label-free aqueous conditions at physiological pH, meaning that proteins and their interactions are assayed in their native conformations and without artefacts introduced by bulky tags or surface interactions. Applications of our platform include rapid size and concentration measurements, the detection of folding/unfolding, binding events, oligomerization, or aggregation, and binding constant determination.

The versatility of our platform and its compatibility with physiological conditions and native states give our technology the potential to make it easier, more accessible and more accurate to characterise the key characteristics of proteins that make our biological world function.

14

Speaking of the Industry world and Research, Pierre-Gilles de Gennes used to say that « both have everything to gain by working together ». Regarding the frontiers between scientific domains, he stressed that we should be able to overcome them in order to make each scientific domain more successful and fully exploit their potentials. Pierre-Gilles de Gennes Institute – IPGG – has been created along these lines of thought: its goal is to bring together, in a cross-disciplinary domain (microfluidics), experts from various disciplines (physics,

biology, chemistry, technology), and develop both fundamental and applied research. Industrial domains interested by microfluidics are numerous (food industry, medicinal field, cosmetics, oil industry, instrumentation, ...).

Two-time future investments (PSL Equipex & Labex), IPGG brings together all of microfluidics research activities on the Montagne Sainte Geneviève. – Paris. IPGG was inaugurated on 14 March 2016 in the presence of the President of the French Republic François Hollande and the Mayor of Paris Anne Hidalgo. IPGG come from 4 top-flight research institution : ESPCI Paris, Curie Institut, ENS et Chimie ParisTech.

.At SuSoS we offer various solutions for surface technology, such as coating products—coated devices or coating chemicals—and services such as coating, surface analysis and contract research.

Since 2004, we have focused on researching the chemical interactions between substrates and coatings. Our knowledge can be divided into:

Polymer-based, thin-film coatings: Using thin films that are only a few nm thick, you can completely change the surface properties of your product. Various functionalities, such as high lubricity under dry and wet conditions, non-fouling properties, or the selective binding of proteins or antibodies on sensor surfaces, can be seamlessly achieved. We also specialize in adhesion promoters and primers.

Coating service: We can coat small series (up to 100 000 parts per annum) right in our own facilities in Dübendorf. With our automated robotic coating system, we are developing industrial coating processes, and supporting our partners with on-site industrial implementation.

Surface-analysis service: With our state-of-the-art analytical technologies, we are able to support you with the characterization of your product and also with product troubleshooting. Chemical and elemental composition, surface topography, coefficient of friction, film thickness or wetting behavior are just some of the many properties we can analyze for you.

Contract Research: We research and implement new technologies; our work is fast, flexible and transparent. Novel applications can be transferred swiftly and easily for your benefit.

What makes us different from our competitors? From our initial contact through to the final implementation, we accompany our clients every step of the way. We attach enormous importance to the all-round service we offer to our customers, from our evaluation of the problem, through advice that is precisely tailor-made to the needs of each customer, to joint project implementation.

z-microsystems is specialist for microfluidic consumables and Lab-

on-a-chip applications, from development to high volume production

of micro-structured plastic parts. Micro-tooling and micro injection

moulding is our passion. 60 years of experience and a fresh and dynamic team is awaiting you. We would

like to be your inspiring partner from the idea to highvolume production

15

May 16th Delegates

Name Organization Country

Pavel Abdulkin Dolomite UK

Bojan Boskovic CfBI UK

William Boulay Cryopak F

Robin de Bruijn Philips NL

Julian Burke Danaher / Leica UK

Sean Devenish Fluidic Analytics UK

Akhila Denduluri Uni Cambridge UK

Antoine Espinet Microfluidx UK

Kierhan Flynn DCU / Fraunhofer IE

Pantelis Georgiou Imperial College UK

Norbert Gotschlich Idexx D

Lukas Greuter IMT CH

Matthew Hayes Evonetix UK

Henne v. Heeren NL

Peter Hewkin CfBI UK

James Howard BD IE

Antonio Lombardo Uni Cambridge UK

Rohit Mishra DCU / Fraunhofer IE

George Malliaras Uni Cambridge UK

Raghu Mokkapati EVG A

Stephanie Ognier IPGG F

Eduard Pelssers Philips NL

Quentin Peter Uni Cambridge UK

Charalampos Pitsalidis Uni Cambridge UK

Smruthi Prasad Danaher / Pall Inc UK

Sebastian Stoeckeler z-Microsystems A

Sonja Smith z-Microsystems A

Yang Su Axcel UK/CN

Michael Tatoulian IPGG F

Samuele Tosatti Susos CH

Mark Treherne Cellesce UK

Jeroen Verheyen Semarion UK

Richard Wales Sartorius Stedim UK

Remi Wache IPGG F

Nour Yakdi Fluigent F

16

May 17th Programme

This is strictly Members Only.

Several MF10 members have asked for specific 1-2-1 / confidential meetings with Cambridge partners

– CfBI is putting in best efforts to make these happen. Members will be responsible for their own

logistics arrangements. Contact Peter Hewkin. Early warning improves the chances of success.

17

Logistics:

Delegates are responsible for making their own travel and accommodation arrangements. Please tell CfBI

how you plan to travel and where you will be staying so we can offer taxi/transfer shares. The information

below will facilitate this.

Cambridge is located 50 miles North of London and is easily accessible by road (M11), rail (London King’s

Cross / St Pancras – trains every 30 mins, journey time circa 50mins) and air.

For international delegates CfBI strongly recommends travel via London Stansted, London City

airport, Gatwick Airport or Eurostar (i.e. NOT Heathrow!)

Once in Cambridge, the meeting venues hotels and dinner site are all within walking distance of each other.

Approximate travel times from Cambridge Main Station

London Stansted Airport (car) - 30 mins; (train – 2 per hour) – 35 mins

London Luton Airport (car) – 50 mins;

London Heathrow Airport (car) – 90 mins; (train) – 120 mins (Underground change at Kings Cross 2 per hour)

London Gatwick Airport (car) – 100 mins; (train 1 per hour) – 110 mins (direct service via Thameslink)

London King’s Cross station / London St Pancras Eurostar station (train 2 fast per hour, 2 slow per hour) –

50 mins (see departures to Cambridge North or Kings Lynn)

18

Accommodation:

Although you might find cheaper accommodation outside town, driving in during the rush hour will be an

expensive nightmare. The following selection of Hotels are all within 10 minutes walk of the MF10 day time

or evening venues:

CfBI Recommendation

Close to Town Centre

Premium

University Arms

Regent St, Cambridge CB2 1AD

https://universityarms.com

£180 +

Other hotel recommendations:

Arundel House Hotel

Chesterton Rd

Cambridge

CB4 3AN

Phone: 01223 367701

Overnight including breakfast: circa £120

Saver Options

IBIS Cambridge Station

£85

19

Close to Science Park Meeting Venue

Premium

The Holiday Inn - Histon Cambridge

Address: Lakeview Bridge Rd Impington, Cambridge CB24 9PH

£150

Saver Option

Travelodge

Chieftain Way, Orchard Park,

Kings Hedges Road, CB4 2WR, United Kingdom

Sat nav postcode: CB4 2WR

£85

20

Orientation

Arundel House Holiday Inn Travelodge Cambridge Science Park meeting venue

Royston London University Arms IBIS (NEW)

Cambridge

North Station

(NEW!)

Christ’s College

Dinner Venue

Cambridge Main

Station

kkk

21

Cambridge Science Park Region

Holiday Inn Travelodge Trinity Centre – meeting venue Cambridge NorthStation

22

Cambridge City Centre

The Eagle Pub Arundel House Hotel Christ’s college The Free Press Pub

University Arms Hotel IBIS Hotel Cambridge Station

Looking for nearby pubs? We recommend: Town Centre

Cambridge Free Press

The Eagle

Questions?:CfBI staff are available before or during the Microfluidics Consortium Meeting to help with

delegate queries. operations@cfbi.com or 07951721110